Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sugen (SUGN) -- Ignore unavailable to you. Want to Upgrade?

To: BulbaMan who wrote (121)	12/17/1997 1:09:00 AM
From: Miljenko Zuanic	Respond to of 550

Thanks Marty. >> I couldn't find any sales of SUGN by Spizzirri -- or any other SUGN insiders for that matter.<< I have some results. This buy transaction by Mr. Spizzirri rely confirm my SUGN optimistic view. I was a bit suspicious about topical SU 5271 in PI/psoriasis. I guess, few weeks of delay may mean that drug have responded patients and remission duration is prolonged which can explain longer PI trials. Company stated that they will immediately after PI move on to large PII, which again indicate that they are very positive on 5271. Regards, mz